# Tibial Delayed Healing Pivotal Clinical Trial

> **NCT01016067** · PHASE3 · TERMINATED · sponsor: **Medtronic Spinal and Biologics** · enrollment: 23 (actual)

## Conditions studied

- Tibial Delayed Healing

## Interventions

- **DEVICE:** INFUSE/MASTERGRAFT
- **PROCEDURE:** Autograft bone

## Key facts

- **NCT ID:** NCT01016067
- **Lead sponsor:** Medtronic Spinal and Biologics
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-11
- **Primary completion:** 2013-10
- **Final completion:** 2013-12
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Difficulty in patient recruitment
- **Last updated:** 2015-01-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01016067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01016067, "Tibial Delayed Healing Pivotal Clinical Trial". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01016067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*